Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2267)
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
17,717
Price
$24.88
Total Value
$440.74K
Shares Held After
675,018
% of Holdings
2.6%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
120,312
Price
$2.50
Total Value
$300.82K
Shares Held After
62,586
% of Holdings
65.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
9,759
Price
$69.23
Total Value
$675.57K
Shares Held After
4,438,447
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,241
Price
$68.39
Total Value
$700.35K
Shares Held After
4,448,206
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,310
Price
$69.20
Total Value
$713.45K
Shares Held After
635,686
% of Holdings
1.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
9,690
Price
$68.36
Total Value
$662.44K
Shares Held After
645,996
% of Holdings
1.5%
MYOMO, INC. (MYO)
KIRK THOMAS F — Director
Shares
72,000
Price
$0.71
Total Value
$51.11K
Shares Held After
553,857
% of Holdings
13.0%
Surgery Partners, Inc. (SGRY)
Brittenham Marissa — Chief Strategy Officer
Shares
3,657
Price
$12.54
Total Value
$45.86K
Shares Held After
94,196
% of Holdings
3.7%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
253
Price
$27.82
Total Value
$7.04K
Shares Held After
76,140
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
3,079
Price
$27.37
Total Value
$84.26K
Shares Held After
76,393
% of Holdings
3.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
10,726
Price
$25.91
Total Value
$277.92K
Shares Held After
79,472
% of Holdings
11.9%
Surgery Partners, Inc. (SGRY)
Burkhalter Danielle — Chief Human Resources Officer
Shares
3,469
Price
$12.83
Total Value
$44.51K
Shares Held After
76,864
% of Holdings
4.3%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
2,957
Price
$18.63
Total Value
$55.08K
Shares Held After
44,757
% of Holdings
6.2%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
1,281
Price
$18.63
Total Value
$23.86K
Shares Held After
6,494
% of Holdings
16.5%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Khattar Jack A. — Director
Shares
120
Price
$51.75
Total Value
$6.21K
Shares Held After
958,100
% of Holdings
0.0%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Khattar Jack A. — Director
Shares
10,742
Price
$51.00
Total Value
$547.84K
Shares Held After
958,220
% of Holdings
1.1%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Khattar Jack A. — Director
Shares
24,138
Price
$50.09
Total Value
$1.21M
Shares Held After
968,962
% of Holdings
2.4%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
1,703
Price
$18.63
Total Value
$31.72K
Shares Held After
19,999
% of Holdings
7.8%
Zai Lab Ltd (ZLAB)
Smiley Joshua L — President and Chief Operating Officer
Shares
1,966
Price
$18.63
Total Value
$36.62K
Shares Held After
91,026
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$542.03
Total Value
$43.36K
Shares Held After
130
% of Holdings
38.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$541.21
Total Value
$259.78K
Shares Held After
210
% of Holdings
69.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$540.27
Total Value
$467.33K
Shares Held After
690
% of Holdings
55.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,546
Price
$539.26
Total Value
$833.70K
Shares Held After
1,555
% of Holdings
49.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,019
Price
$538.31
Total Value
$1.09M
Shares Held After
3,101
% of Holdings
39.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,030
Price
$537.29
Total Value
$1.09M
Shares Held After
5,120
% of Holdings
28.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,536
Price
$536.32
Total Value
$823.79K
Shares Held After
7,150
% of Holdings
17.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
944
Price
$535.43
Total Value
$505.44K
Shares Held After
8,686
% of Holdings
9.8%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
1,703
Price
$99.71
Total Value
$169.81K
Shares Held After
65,604
% of Holdings
2.5%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,597
Price
$98.83
Total Value
$256.66K
Shares Held After
67,307
% of Holdings
3.7%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
804
Price
$97.89
Total Value
$78.70K
Shares Held After
69,904
% of Holdings
1.1%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
10,000
Price
$4.29
Total Value
$42.90K
Shares Held After
1,086,467
% of Holdings
0.9%
BRUKER CORP (BRKR)
Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Shares
2,000
Price
$35.44
Total Value
$70.88K
Shares Held After
128,443
% of Holdings
1.5%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
6,565
Price
$21.52
Total Value
$141.28K
Shares Held After
226,804
% of Holdings
2.8%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
5,280
Price
$48.91
Total Value
$258.24K
Shares Held After
96,200
% of Holdings
5.2%
Privia Health Group, Inc. (PRVA)
Mehrotra Parth — Director
Shares
27,229
Price
$21.52
Total Value
$585.97K
Shares Held After
581,952
% of Holdings
4.5%
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Christianson Mark — Business Development Director
Shares
100
Price
$0.80
Total Value
$80.00
Shares Held After
214,283
% of Holdings
0.0%
Nutex Health Inc. (NUTX)
Montgomery Pamela W. — Chief Legal Officer-Healthcare
Shares
79
Price
$88.87
Total Value
$7.02K
Shares Held After
2,758
% of Holdings
2.9%
Senseonics Holdings, Inc. (SENS)
ROEDER DOUGLAS A — Director
Shares
17,500
Price
$5.73
Total Value
$100.28K
Shares Held After
119,731
% of Holdings
14.6%
Senseonics Holdings, Inc. (SENS)
Goodnow Timothy T — Director
Shares
17,225
Price
$5.79
Total Value
$99.73K
Shares Held After
651,243
% of Holdings
2.6%
MBX Biosciences, Inc. (MBX)
Hawryluk P. Kent — Director
Shares
18,500
Price
$28.41
Total Value
$525.66K
Shares Held After
486,777
% of Holdings
3.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$12.96
Total Value
$247.02K
Shares Held After
507,934
% of Holdings
3.6%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
1,410
Price
$55.23
Total Value
$77.87K
Shares Held After
7,069
% of Holdings
16.6%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
7,308
Price
$55.23
Total Value
$403.58K
Shares Held After
19,923
% of Holdings
26.8%
Xenon Pharmaceuticals Inc. (XENE)
DiFabio Andrea — Chief Legal Officer
Shares
1,342
Price
$55.23
Total Value
$74.11K
Shares Held After
7,301
% of Holdings
15.5%
STAAR SURGICAL CO (STAA)
BROADWOOD PARTNERS, L.P. — Director
Shares
316,017
Price
$18.61
Total Value
$5.88M
Shares Held After
16,123,842
% of Holdings
2.0%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
11,943
Price
$27.16
Total Value
$324.34K
Shares Held After
65,925
% of Holdings
15.3%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
61,253
Price
$26.17
Total Value
$1.60M
Shares Held After
77,868
% of Holdings
44.0%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
12,068
Price
$27.13
Total Value
$327.44K
Shares Held After
62,085
% of Holdings
16.3%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
107,961
Price
$26.15
Total Value
$2.82M
Shares Held After
74,153
% of Holdings
59.3%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$72.62
Total Value
$36.31K
Shares Held After
79,390
% of Holdings
0.6%
Showing 551–600 of 2267 transactions (page 12 of 46)